Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Lee

Showing results (161-170 of 168) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 168 results.
Emerging Infectious Diseases|September 30, 2010
Risk factors for pandemic (H1N1) 2009 virus seroconversion among hospital staff, SingaporeMark I C Chen, Vernon J M Lee, Ian Barr, et al.
EMBO Molecular Medicine|May 22, 2023
Control of fibrosis with enhanced safety via asymmetric inhibition of prolyl-tRNA synthetase 1Ina Yoon, Sulhee Kim, Minjae Cho, et al.
Journal of Pharmaceutical Sciences|July 19, 2011
Development of a new permeability assay using low-efflux MDCKII cellsLi Di, Carrie Whitney-Pickett, John P Umland, et al.
Circulation|July 17, 2023
Associations Between Maternal Sociodemographics and Hospital Mortality in Newborns With Prenatally Diagnosed Hypoplastic Left Heart SyndromeKeila N Lopez, Shaine A Morris, Anita Krishnan, et al.
Circulation|May 17, 2021
Impact of Socioeconomic Status, Race and Ethnicity, and Geography on Prenatal Detection of Hypoplastic Left Heart Syndrome and Transposition of the Great ArteriesAnita Krishnan, Marni B Jacobs, Shaine A Morris, et al.
The Journal of Infectious Diseases|October 8, 2022
Engaging Same-Day Peer Ambassadors to Increase Coronavirus Disease 2019 Vaccination Among People Experiencing Unsheltered Homelessness in Los Angeles County: A Hybrid Feasibility-Evaluation StudyChelsea L Shover, Allison Rosen, José Mata, et al.
JAMA Network Open|June 1, 2026
Early Neurodevelopmental Outcomes in Children With Congenital Heart DiseaseMike Seed, Dawn Ilardi, Valerie Rofeberg, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 27, 2013
Variability in P-glycoprotein inhibitory potency (IC₅₀) using various in vitro experimental systems: implications for universal digoxin drug-drug interaction risk assessment decision criteriaJoe Bentz, Michael P O'Connor, Dallas Bednarczyk, et al.
Pageof 17

Showing results (161-170 of 168) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 168 results.
Emerging Infectious Diseases|September 30, 2010
Risk factors for pandemic (H1N1) 2009 virus seroconversion among hospital staff, SingaporeMark I C Chen, Vernon J M Lee, Ian Barr, et al.
EMBO Molecular Medicine|May 22, 2023
Control of fibrosis with enhanced safety via asymmetric inhibition of prolyl-tRNA synthetase 1Ina Yoon, Sulhee Kim, Minjae Cho, et al.
Journal of Pharmaceutical Sciences|July 19, 2011
Development of a new permeability assay using low-efflux MDCKII cellsLi Di, Carrie Whitney-Pickett, John P Umland, et al.
Circulation|July 17, 2023
Associations Between Maternal Sociodemographics and Hospital Mortality in Newborns With Prenatally Diagnosed Hypoplastic Left Heart SyndromeKeila N Lopez, Shaine A Morris, Anita Krishnan, et al.
Circulation|May 17, 2021
Impact of Socioeconomic Status, Race and Ethnicity, and Geography on Prenatal Detection of Hypoplastic Left Heart Syndrome and Transposition of the Great ArteriesAnita Krishnan, Marni B Jacobs, Shaine A Morris, et al.
The Journal of Infectious Diseases|October 8, 2022
Engaging Same-Day Peer Ambassadors to Increase Coronavirus Disease 2019 Vaccination Among People Experiencing Unsheltered Homelessness in Los Angeles County: A Hybrid Feasibility-Evaluation StudyChelsea L Shover, Allison Rosen, José Mata, et al.
JAMA Network Open|June 1, 2026
Early Neurodevelopmental Outcomes in Children With Congenital Heart DiseaseMike Seed, Dawn Ilardi, Valerie Rofeberg, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 27, 2013
Variability in P-glycoprotein inhibitory potency (IC₅₀) using various in vitro experimental systems: implications for universal digoxin drug-drug interaction risk assessment decision criteriaJoe Bentz, Michael P O'Connor, Dallas Bednarczyk, et al.
Pageof 17